{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:31:16Z","timestamp":1790706676237,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,13]]},"abstract":"<jats:p>\n                    This study aims to use echocardiography to explore the prevalence of pulmonary hypertension (PH) in maintenance hemodialysis patients with different vascular accesses and analyze the risk factors for combined PH. A cross-sectional analysis was conducted on 757 end-stage renal disease patients receiving maintenance hemodialysis. Patients were categorized by the type of access used during echocardiographic examination: central vein catheter (CVC) and autogenous arteriovenous fistula (AVF)\/arteriovenous graft (AVG). They were further grouped by tricuspid regurgitation velocity to determine PH prevalence. Multinomial logistic regression analysis evaluated the relevant risk factors. (1) Among maintenance hemodialysis patients, 39.23% had a moderate to high likelihood of PH; 248 patients (32.76%) had diastolic dysfunction, 184 patients (24.31%) had pericardial effusion, 381 patients (50.33%) had left ventricular hypertrophy, and 268 patients (35.40%) had aortic regurgitation. Diastolic dysfunction may indicate early heart failure and PH progression. (2) In the CVC group, 62 patients (24.22%) had moderate PH, and 9 (3.52%) had severe PH. Left atrium diameter (OR\u2005=\u20051.086, 95% CI 1.024\u20131.151,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006 and OR\u2005=\u20051.123, 95% CI 1.001\u20131.260,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.048) showed statistical significance in moderate and severe PH groups, respectively. Right ventricular end-systolic diameter (RVDS) (OR\u2005=\u20051.519, 95% CI 1.151\u20132.005,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003) was significant in the severe PH group. (3) In the AVF\/AVG group, 158 patients (31.54%) had moderate PH, and 68 (13.57%) had severe PH. RVDS (OR\u2005=\u20051.183, 95% CI 1.078\u20131.298,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001 and OR\u2005=\u20051.607, 95% CI 1.413\u20131.829,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) showed significance in moderate and severe PH groups. Left atrium diameter (OR\u2005=\u20051.060, 95% CI 1.004\u20131.120,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.035) showed significance in the severe PH group. The incidence of PH in maintenance hemodialysis patients is high and is closely related to volume overload, vascular access type, and right ventricular enlargement. For patients with right ventricular dilation (e.g., RVDS\u2005&gt;\u200525\u2009mm) or moderate to severe PH, careful evaluation of the benefit-risk ratio for AVF\/AVG should be conducted. In selected high-risk cases, alternative access such as CVC may be appropriate. Prospective studies are needed to further compare the long-term effects of different access types on PH progression.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043845","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:00:16Z","timestamp":1771005616000},"page":"e43845","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and risk factors of pulmonary hypertension in maintenance hemodialysis patients based on echocardiography"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1077-9809","authenticated-orcid":false,"given":"Jingwen","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Hemodialysis, Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260216","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease.","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"R2-20260216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"R3-20260216","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2017.11.018","article-title":"Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis.","volume":"72","author":"Tang","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R4-20260216","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1708538119866616","article-title":"Assessment of right heart functions in the patients with arteriovenous fistula for hemodialysis access: right ventricular free wall strain and tricuspid regurgitation jet velocity as the predictors of right heart failure.","volume":"28","author":"Gumus","year":"2019","journal-title":"Vascular"},{"key":"R5-20260216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-018-0866-9","article-title":"Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study.","volume":"19","author":"Zhang","year":"2018","journal-title":"BMC Nephrol"},{"key":"R6-20260216","first-page":"1","article-title":"Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study.","volume":"7","author":"Duffield","year":"2012","journal-title":"PLoS One"},{"key":"R7-20260216","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1053\/j.ajkd.2012.07.029","article-title":"Pulmonary hypertension in CKD.","volume":"61","author":"Bolignano","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R8-20260216","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000350952","article-title":"Pulmonary hypertension and right heart failure in chronic kidney disease: new challenge for 21st-century cardionephrologists.","volume":"3","author":"Di Lullo","year":"2013","journal-title":"Cardiorenal Med"},{"key":"R9-20260216","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension.","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R10-20260216","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"R11-20260216","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.amjcard.2012.06.012","article-title":"Echocardiography in pulmonary arterial hypertension.","volume":"110","author":"Forfia","year":"2012","journal-title":"Am J Cardiol"},{"key":"R12-20260216","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"Comments on \u201cKDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.\u201d.","volume":"84","author":"Andrassy","year":"2013","journal-title":"Kidney Int"},{"key":"R14-20260216","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.echo.2013.07.009","article-title":"Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.","volume":"26","author":"Hahn","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"R16-20260216","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"R18-20260216","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/ERP-19-0050","article-title":"Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British Society of Echocardiography.","volume":"7","author":"Harkness","year":"2020","journal-title":"Echo Res Pract"},{"key":"R19-20260216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-022-02506-y","article-title":"Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants.","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"R20-20260216","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cca.2021.06.003","article-title":"Serum leptin concentration can predict cardiovascular outcomes and all-cause death in maintenance hemodialysis patients.","volume":"520","author":"Qin","year":"2021","journal-title":"Clin Chim Acta"},{"key":"R21-20260216","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.echo.2021.12.003","article-title":"Associations between myocardial diastolic dysfunction and cardiovascular mortality in chronic kidney disease: a large single-center cohort study.","volume":"35","author":"Liang","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"R22-20260216","first-page":"100389","article-title":"Aortic stiffness is independently associated with interstitial myocardial fibrosis by native T1 and accelerated in the presence of chronic kidney disease.","volume":"24","author":"Chen","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R23-20260216","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/sdi.12694","article-title":"Hemodialysis\u2010induced cardiovascular disease.","volume":"31","author":"Ahmadmehrabi","year":"2018","journal-title":"Semin Dial"},{"key":"R24-20260216","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12872-019-1256-3","article-title":"Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes.","volume":"19","author":"Price","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"R25-20260216","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.121.057666","article-title":"Myocardial edema provides a link between pulmonary arterial hypertension and pericardial effusion.","volume":"145","author":"Stewart","year":"2022","journal-title":"Circulation"},{"key":"R26-20260216","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1378\/chest.12-3033","article-title":"Pericardial effusions in pulmonary arterial hypertension.","volume":"144","author":"Fenstad","year":"2013","journal-title":"Chest"},{"key":"R27-20260216","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijcard.2020.03.002","article-title":"Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions \u2013 comparison of uremic, hypertensive and hypertrophic cardiomyopathy.","volume":"306","author":"Arcari","year":"2020","journal-title":"Int J Cardiol"},{"key":"R28-20260216","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/jpm11080734","article-title":"Cardiorenal syndrome: emerging role of medical imaging for clinical diagnosis and management.","volume":"11","author":"Lin","year":"2021","journal-title":"J Pers Med"},{"key":"R29-20260216","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1161\/ATVBAHA.119.312946","article-title":"ALDH2 (Aldehyde Dehydrogenase 2) protects against hypoxia-induced pulmonary hypertension.","volume":"39","author":"Zhao","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R30-20260216","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","article-title":"Iron balance and the role of hepcidin in chronic kidney disease.","volume":"36","author":"Ganz","year":"2016","journal-title":"Semin Nephrol"},{"key":"R31-20260216","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1681\/ASN.2014111111","article-title":"Prevalence, predictors, and outcomes of pulmonary hypertension in CKD.","volume":"27","author":"Navaneethan","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R32-20260216","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2215\/CJN.10191013","article-title":"Presence and outcomes of kidney disease in patients with pulmonary hypertension.","volume":"9","author":"Navaneethan","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R33-20260216","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamasurg.2014.3484","article-title":"Trends in incident hemodialysis access and mortality.","volume":"150","author":"Malas","year":"2015","journal-title":"JAMA Surg"},{"key":"R34-20260216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.119.012073","article-title":"Diastolic pulmonary gradient as a predictor of right ventricular failure after left ventricular assist device implantation.","volume":"8","author":"Alnsasra","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R35-20260216","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.115.018935","article-title":"SIRT3\u2013AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction.","volume":"133","author":"Lai","year":"2016","journal-title":"Circulation"},{"key":"R36-20260216","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/ATVBAHA.119.313883","article-title":"Treatment with treprostinil and metformin normalizes hyperglycemia and improves cardiac function in pulmonary hypertension associated with heart failure with preserved ejection fraction.","volume":"40","author":"Wang","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R37-20260216","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.3390\/cells10113178","article-title":"Expanding the evidence of a semi-dominant inheritance in GDF2 associated with pulmonary arterial hypertension.","volume":"10","author":"Gallego","year":"2021","journal-title":"Cells"},{"key":"R38-20260216","doi-asserted-by":"crossref","first-page":"H1862","DOI":"10.1152\/ajpheart.00535.2020","article-title":"Carvedilol and exercise combination therapy improves systolic but not diastolic function and reduces plasma osteopontin in Col4a3\u2212\/\u2212 Alport mice.","volume":"320","author":"Dunkley","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R39-20260216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2022.2518","article-title":"Association of echocardiographic measures of left atrial function and size with incident dementia.","volume":"327","author":"Wang","year":"2022","journal-title":"JAMA"},{"key":"R40-20260216","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3348\/kjr.2020.1485","article-title":"Late gadolinium enhancement of left ventricular papillary muscles in patients with mitral regurgitation.","volume":"22","author":"Lim","year":"2021","journal-title":"Korean J Radiol"},{"key":"R41-20260216","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary hypertension in HFpEF and HFrEF.","volume":"76","author":"Guazzi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R42-20260216","doi-asserted-by":"crossref","first-page":"908040","DOI":"10.3389\/fcvm.2022.908040","article-title":"A bibliometric and visualized analysis of uremic cardiomyopathy from 1990 to 2021.","volume":"9","author":"Bao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R43-20260216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1841527","article-title":"Resveratrol prevents right ventricle remodeling and dysfunction in monocrotaline-induced pulmonary arterial hypertension with a limited improvement in the lung vasculature.","volume":"2020","author":"V\u00e1zquez-Garza","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R44-20260216","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14779072.2018.1449646","article-title":"Evaluation of the right ventricle by echocardiography: particularities and major challenges.","volume":"16","author":"Dandel","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R46-20260216","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/674750","article-title":"Right heart failure: toward a common language.","volume":"3","author":"Mehra","year":"2013","journal-title":"Pulm Circ"},{"key":"R47-20260216","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.","volume":"58","author":"Van De Veerdonk","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R48-20260216","first-page":"529","article-title":"Right ventricular function and right-heart echocardiographic response to therapy predict long-term outcome in patients with pulmonary hypertension.","volume":"31","author":"Sano","year":"2015","journal-title":"Can J Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:01:51Z","timestamp":1771257711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043845","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"2025-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}